MONTPELLIER, France, Sept. 24, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is proud to announce that it will highlight its ROSA™ robotic surgery system at the 2015 Congress of Neurological Surgeons (CNS) Annual Meeting, held in New Orleans (USA) from September 28 to 30, 2015.
The CNS Annual Meeting is a premier forum gathering around 3,000 specialists in the field of neurosurgery and featuring the most cutting-edge procedures, approaches, and technologies in the field. MEDTECH will be exhibiting two ROSA™ robotic surgery systems at its booth (#417) for hands-on demonstrations of surgical procedures on the brain and spine.
About MEDTECH
Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.
In 2013 MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.